{"context":{"query":">>uniprot>>reactome","source_dataset":"uniprot","target_dataset":"reactome"},"stats":{"queried":3,"total":89,"mapped":3},"pagination":{"has_next":false},"schema":"id|name|tax_id|is_disease_pathway","mappings":[{"input":"P29597","source":"P29597|Non-receptor tyrosine-protein kinase TYK2","targets":["R-HSA-1059683|Interleukin-6 signaling|9606|false","R-HSA-110056|MAPK3 (ERK1) activation|9606|false","R-HSA-112411|MAPK1 (ERK2) activation|9606|false","R-HSA-449836|Other interleukin signaling|9606|false","R-HSA-6783783|Interleukin-10 signaling|9606|false","R-HSA-6785807|Interleukin-4 and Interleukin-13 signaling|9606|false","R-HSA-6788467|IL-6-type cytokine receptor ligand interactions|9606|false","R-HSA-8854691|Interleukin-20 family signaling|9606|false","R-HSA-8984722|Interleukin-35 Signalling|9606|false","R-HSA-9020591|Interleukin-12 signaling|9606|false","R-HSA-9020933|Interleukin-23 signaling|9606|false","R-HSA-9020956|Interleukin-27 signaling|9606|false","R-HSA-909733|Interferon alpha/beta signaling|9606|false","R-HSA-912694|Regulation of IFNA/IFNB signaling|9606|false","R-HSA-9674555|Signaling by CSF3 (G-CSF)|9606|false","R-HSA-9679191|Potential therapeutics for SARS|9606|true","R-HSA-9705462|Inactivation of CSF3 (G-CSF) signaling|9606|false","R-HSA-9705671|SARS-CoV-2 activates/modulates innate and adaptive immune responses|9606|true","R-HSA-9725370|Signaling by ALK fusions and activated point mutants|9606|true","R-HSA-9833109|Evasion by RSV of host interferon responses|9606|true"]},{"input":"P23458","source":"P23458|Tyrosine-protein kinase JAK1","targets":["R-HSA-1059683|Interleukin-6 signaling|9606|false","R-HSA-110056|MAPK3 (ERK1) activation|9606|false","R-HSA-112411|MAPK1 (ERK2) activation|9606|false","R-HSA-1169408|ISG15 antiviral mechanism|9606|false","R-HSA-1266695|Interleukin-7 signaling|9606|false","R-HSA-449836|Other interleukin signaling|9606|false","R-HSA-5673001|RAF/MAP kinase cascade|9606|false","R-HSA-6783783|Interleukin-10 signaling|9606|false","R-HSA-6785807|Interleukin-4 and Interleukin-13 signaling|9606|false","R-HSA-6788467|IL-6-type cytokine receptor ligand interactions|9606|false","R-HSA-877300|Interferon gamma signaling|9606|false","R-HSA-877312|Regulation of IFNG signaling|9606|false","R-HSA-8854691|Interleukin-20 family signaling|9606|false","R-HSA-8983432|Interleukin-15 signaling|9606|false","R-HSA-8984722|Interleukin-35 Signalling|9606|false","R-HSA-8985947|Interleukin-9 signaling|9606|false","R-HSA-9020558|Interleukin-2 signaling|9606|false","R-HSA-9020591|Interleukin-12 signaling|9606|false","R-HSA-9020956|Interleukin-27 signaling|9606|false","R-HSA-9020958|Interleukin-21 signaling|9606|false","R-HSA-909733|Interferon alpha/beta signaling|9606|false","R-HSA-912526|Interleukin receptor SHC signaling|9606|false","R-HSA-912694|Regulation of IFNA/IFNB signaling|9606|false","R-HSA-9674555|Signaling by CSF3 (G-CSF)|9606|false","R-HSA-9679191|Potential therapeutics for SARS|9606|true","R-HSA-9705462|Inactivation of CSF3 (G-CSF) signaling|9606|false","R-HSA-9705671|SARS-CoV-2 activates/modulates innate and adaptive immune responses|9606|true","R-HSA-9732724|IFNG signaling activates MAPKs|9606|false","R-HSA-9833109|Evasion by RSV of host interferon responses|9606|true","R-HSA-9931295|PD-L1(CD274) glycosylation and translocation to plasma membrane|9606|false"]},{"input":"P40763","source":"P40763|Signal transducer and activator of transcription 3","targets":["R-HSA-1059683|Interleukin-6 signaling|9606|false","R-HSA-111453|BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members|9606|false","R-HSA-1266695|Interleukin-7 signaling|9606|false","R-HSA-1433557|Signaling by SCF-KIT|9606|false","R-HSA-1839117|Signaling by cytosolic FGFR1 fusion mutants|9606|true","R-HSA-186763|Downstream signal transduction|9606|false","R-HSA-198745|Signalling to STAT3|9606|false","R-HSA-201556|Signaling by ALK|9606|false","R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP)|9606|false","R-HSA-2586552|Signaling by Leptin|9606|false","R-HSA-2892247|POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation|9606|false","R-HSA-390471|Association of TriC/CCT with target proteins during biosynthesis|9606|false","R-HSA-452723|Transcriptional regulation of pluripotent stem cells|9606|false","R-HSA-6783783|Interleukin-10 signaling|9606|false","R-HSA-6785807|Interleukin-4 and Interleukin-13 signaling|9606|false","R-HSA-8849474|PTK6 Activates STAT3|9606|false","R-HSA-8854691|Interleukin-20 family signaling|9606|false","R-HSA-8875791|MET activates STAT3|9606|false","R-HSA-8983432|Interleukin-15 signaling|9606|false","R-HSA-8984722|Interleukin-35 Signalling|9606|false","R-HSA-8985947|Interleukin-9 signaling|9606|false","R-HSA-9008059|Interleukin-37 signaling|9606|false","R-HSA-9020933|Interleukin-23 signaling|9606|false","R-HSA-9020956|Interleukin-27 signaling|9606|false","R-HSA-9020958|Interleukin-21 signaling|9606|false","R-HSA-9616222|Transcriptional regulation of granulopoiesis|9606|false","R-HSA-9670439|Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants|9606|true","R-HSA-9673767|Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants|9606|true","R-HSA-9673770|Signaling by PDGFRA extracellular domain mutants|9606|true","R-HSA-9674555|Signaling by CSF3 (G-CSF)|9606|false","R-HSA-9680350|Signaling by CSF1 (M-CSF) in myeloid cells|9606|false","R-HSA-9701898|STAT3 nuclear events downstream of ALK signaling|9606|false","R-HSA-9705462|Inactivation of CSF3 (G-CSF) signaling|9606|false","R-HSA-9707564|Cytoprotection by HMOX1|9606|false","R-HSA-9725370|Signaling by ALK fusions and activated point mutants|9606|true","R-HSA-9725371|Nuclear events stimulated by ALK signaling in cancer|9606|true","R-HSA-982772|Growth hormone receptor signaling|9606|false","R-HSA-9833482|PKR-mediated signaling|9606|false","R-HSA-9909649|Regulation of PD-L1(CD274) transcription|9606|false"]}]}